Frank Avilucea, MD
Orthopaedic Trauma · Orlando, FLNPI 1548403389
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Smith+Nephew at 49.6% of the total. Reporting peaked in 2019 at $63,653 and has fallen 96.0% since, to $2,575 in 2025.
Across 306 payments — averaging $624.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$95K
- Zimmer Biomet$78K
- Synthes USA Products LLC$8K
- Stryker$5K
- Globus Medical$2K
- Medical Device Business Services, Inc.$1K
- plus $2K from 10 others
What the payments were for
- Consulting fees$95,16350%
- Speaking & faculty fees$56,23829%
- Travel & lodging$23,43012%
- Food & beverage$16,0718%
- Education$460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 132 | $94,704 |
| Zimmer Biomet | 88 | $77,612 |
| Synthes USA Products LLC | 7 | $8,026 |
| Stryker | 43 | $5,079 |
| Globus Medical | 10 | $2,425 |
| Medical Device Business Services, Inc. | 3 | $1,196 |
| Johnson & Johnson | 7 | $816 |
| Biocomposites Inc | 4 | $289 |
| ERMI LLC | 4 | $227 |
| Innovation Technologies Inc | 2 | $184 |
| Curvafix, Inc. | 1 | $140 |
| Reel Surgical, Inc. | 1 | $105 |
| Integra Lifesciences Corporation | 1 | $75 |
| Depuy Synthes Products, Inc. | 1 | $34 |
| Sanara Medtech Inc. | 1 | $22 |
| Acumed LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOS$76,328
- Journey II$51,196
- REAL INTELLIGENCE$38,459
- CANNULATED SCREWS$37,050
- EVOS MINI$35,849
- Affixus$31,101
- Alps Plates and Instruments$26,750
- Legion Revision$17,330
- Alps Elbow$15,000
- Alps Hand$14,875
- TRIGEN$14,613
- PHOENIX$14,250
- DVR Crosslock Plates/Screws/Pegs$14,250
- XtraFix$14,247
- TRIGEN InterTAN$12,331
- LCP$8,190
- RI.HIP NAVIGATION$6,352
- ACCOLADE$3,923
- REDAPT$3,796
- Legion$1,920
How this compares
$190,946 in reported general payments places this provider in the 85th percentile of 65 orthopaedic trauma providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $311 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $217 |
| Methocarbamol | 18 | $132 |
| Methylprednisolone | 17 | $125 |
| Meloxicam | 29 | $96 |
| Cephalexin | 14 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Orlando
- J Dean ColeOrlando$4.2M
- Vuong NguyenOrlando$1.4M
- Kenneth KovalOrlando$321K
- Mohamed ShaathOrlando$303K
- Barrett HawkinsOrlando$26K
- Jonathan YawmanOrlando$9K
- Edward PerezFt Lauderdale$981K
- Hassan MirTemple Terrace$877K
- Daniel SeginaMelbourne$330K
- Daniel DziadoszSt Petersburg$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.